Centennial Mental Health Center, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 80 E 1st St N, Cheyenne Wells, CO 80810 Phone: 719-346-8183 |
Centennial Mental Health Center, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 80 East 1st Street Suite 2, Cheyenne Wells, CO 80810 Phone: 970-522-4549 |
Inspire Consulting & Counseling, Pc, Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 80 E 1st N, Ste 3, Cheyenne Wells, CO 80810 Phone: 720-231-0353 |
Centennial Mental Health Center, Inc. Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 80 E 1st Street, Suite 2, Cheyenne Wells, CO 80810 Phone: 719-346-8183 Fax: 719-346-0292 |
News Archive
Today at the annual scientific sessions of the American Heart Association, the first U.S. clinical trial data on the Melody transcatheter pulmonary valve were presented. These findings also represent the first U.S. data on transcatheter valves in a population with congenital heart disease and the first reported U.S. data on the use of a transcatheter valve in the pulmonary position. The Melody valve is currently investigational in the U.S.
CEL-SCI Corporation today announced that the Company held a clinical investigator meeting during the week of November 14th for its Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer.
Many studies show that video gamers perform better than non-gamers on certain visual tasks, like managing distractors and identifying targets, but a small new Brown University study provides gamers with some cognitive bonus points. The study results suggest that gaming not only improves their visual skill but also may improve their learning ability for those skills.
A new study published on the medRxiv* preprint server presents a standardized survey instrument for evaluating risk factors associated with bidirectional zoonotic transmission of SARS-CoV-2 and pathogens. The instrument is particularly focused on settings where humans and animals share close contact.
Oasmia Pharmaceutical AB, developer of a new generation of drugs within human and veterinary oncology, announced today the topline findings from a head-to-head comparison study of its lead human cancer product candidate Paclical and Celgene's Abraxane, which show similar pharmacokinetic (PK) profiles of the two products. The study was conducted in women with metastatic breast cancer.
› Verified 8 days ago